RoB 2: a Revised Tool for Assessing Risk of Bias in Randomised Trials
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
The Trouble with Girls: Obstacles to Women's Success in Medicine and Research
In 1856, Eunice Foote had to listen to a man present her paper because of her sex. In 2019, women undoubtedly have greater access to academic training, support, and mentorship than in the mid-19th century. But the ultimate and fundamental sex equality that Foote and her colleagues called for in 1848 has yet to be achieved in medicine, nursing, public health, and the sciences.
A Lexicon for Gender Bias in Academia and Medicine
Mansplaining is the tip of the iceberg Many of the experiences of women in the workforce are so patterned and commonplace they have spawned an emerging vocabulary, which includes terms like mansplaining (explaining something in a condescending or patronising way, typically to a woman), bropropriation (when a man takes credit for a woman's idea), manel (a panel of speakers populated entirely by men), and himpathy (the "inappropriate and disproportionate sympathy powerful men often enjoy in cases of sexual assault, intimate partner violence, homicide, and other misogynistic behavior"). Here, we propose a number of additions to the vernacular, which are likely to remain relevant for the foreseeable future.